creatine and glp 1 GLP-1 Use in Non-Diabetics Associated with Trivial Increase in Creatinine Optimize Your Weight Loss Journey

Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury

Mitochondrial Dysfunction in Diabetic Cardiomyopathy: Effect of Mesenchymal Stem Cell with PPAR- Agonist or Exendin-4

The result is high quality health care that is accessible, comprehensive, and, most of all, personalized

doi: 10.1093/cvr/cvae216, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 42

Kim MK, Baek KH, Song KH, Il Kang M, Park CY, Lee WY, et al

Already, the impact is being felt, as Walmart attested in their latest earnings call: This article will hopefully serve as a primer for not just GLP-1s, but a springboard for a discussion on potential secondary knock-on effects in both patients taking them and the wider economy